This article is part of a series that provides an ongoing analysis of the changes made to Wedgewood Partners’ 13F stock portfolio on a quarterly basis. It is based on David Rolfe’s regulatory 13F Form filed on 04/29/2020. The 13F portfolio value decreased ~47% from $987M to $528M this quarter. The holdings are concentrated with recent 13F reports showing around 30 positions. There are 21 securities that are significantly large (more than ~0.5% of the portfolio each) and they are the focus of this article. The largest five stakes are Apple Inc. (AAPL), Edwards Lifesciences